Nursing Elites

1. What is a condition where the lungs become stiff and scarred, making it difficult to breathe and get enough oxygen into the bloodstream?

• A. Pulmonary fibrosis
• B. Pulmonary edema
• C. Pulmonary embolism
• D. Pulmonary hypertension

Correct answer: A

Rationale: Pulmonary fibrosis is a condition characterized by the stiffening and scarring of the lungs, leading to difficulty breathing and impairing the transfer of oxygen into the bloodstream. Pulmonary edema refers to fluid accumulation in the lungs, causing breathing difficulties due to fluid filling the air sacs. Pulmonary embolism is a blockage in one of the pulmonary arteries in the lungs, often caused by a blood clot. Pulmonary hypertension is high blood pressure in the arteries of the lungs, which can lead to strain on the heart and affect oxygen levels in the blood.

2. The healthcare provider is monitoring a client on an ACE inhibitor. What lab value is most important to monitor?

• A. Potassium
• B. Sodium
• C. Creatinine
• D. Calcium

Correct answer: A

Rationale: The correct answer is A: Potassium. When a client is on an ACE inhibitor, it is crucial to monitor potassium levels because ACE inhibitors can lead to an increase in potassium, potentially causing hyperkalemia. Monitoring sodium levels (Choice B) is not as critical in this scenario. Creatinine levels (Choice C) are important for assessing kidney function but are not the most crucial lab value to monitor with ACE inhibitors. Calcium levels (Choice D) are not directly affected by ACE inhibitors and are not the priority for monitoring in this case.

3. The nurse is monitoring a client on dobutamine. What adverse effect should the nurse watch for?

• A. Tachycardia
• B. Bradycardia
• C. Hypertension
• D. Respiratory distress

Correct answer: A

Rationale: The correct answer is A: Tachycardia. Dobutamine is a medication that stimulates beta-1 adrenergic receptors in the heart, leading to increased heart rate. Therefore, tachycardia is a common adverse effect that the nurse should monitor for. Choices B, C, and D are incorrect because dobutamine typically does not cause bradycardia, hypertension, or respiratory distress as its primary adverse effects.

4. What is a condition where the heart beats too slowly, reducing the amount of blood pumped to the body?

• A. Bradycardia
• B. Tachycardia
• C. Atrial fibrillation
• D. Ventricular fibrillation

Correct answer: A

Rationale: Bradycardia is the correct answer. It is a condition characterized by a slow heart rate, which reduces the amount of blood pumped to the body. This can lead to symptoms like fatigue and dizziness. Choice B, Tachycardia, is the opposite condition where the heart beats too fast. Choices C and D, Atrial fibrillation and Ventricular fibrillation, refer to irregular and potentially life-threatening rapid heart rhythms involving the atria and ventricles respectively, not a slow heart rate.

5. A client on spironolactone (Aldactone) has a potassium level of 6.0 mEq/L. What is the nurse’s priority action?

• A. Hold the spironolactone and notify the healthcare provider.
• B. Administer a potassium supplement.
• C. Continue the spironolactone as ordered.
• D. Increase the dose of spironolactone.

Correct answer: A

Rationale: The correct action for a client on spironolactone with a potassium level of 6.0 mEq/L is to hold the medication and notify the healthcare provider. Spironolactone is a potassium-sparing diuretic that can further elevate potassium levels, which are already high. Administering a potassium supplement (Choice B) would exacerbate the hyperkalemia. Continuing the spironolactone as ordered (Choice C) could lead to worsening hyperkalemia. Increasing the dose of spironolactone (Choice D) would be contraindicated in the presence of elevated potassium levels.

Similar Questions